{"id":"https://openalex.org/W3047360916","doi":"https://doi.org/10.1158/1535-7163.mct-20-0160","title":"PIM Kinase Inhibitors Block the Growth of Primary T-cell Acute Lymphoblastic Leukemia: Resistance Pathways Identified by Network Modeling Analysis","display_name":"PIM Kinase Inhibitors Block the Growth of Primary T-cell Acute Lymphoblastic Leukemia: Resistance Pathways Identified by Network Modeling Analysis","publication_year":2020,"publication_date":"2020-08-04","ids":{"openalex":"https://openalex.org/W3047360916","doi":"https://doi.org/10.1158/1535-7163.mct-20-0160","mag":"3047360916","pmid":"https://pubmed.ncbi.nlm.nih.gov/32753387","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7484401"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.mct-20-0160","doi":"https://doi.org/10.1158/1535-7163.mct-20-0160","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-20-0160","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7484401","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078320628","display_name":"James T. Lim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I138006243","display_name":"University of Arizona","ror":"https://ror.org/03m2x1q45","country_code":"US","type":"education","lineage":["https://openalex.org/I138006243"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James T. Lim","raw_affiliation_strings":["1Department of Molecular and Cellular Biology, University of Arizona, Tucson, Arizona"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Molecular and Cellular Biology, University of Arizona, Tucson, Arizona","institution_ids":["https://openalex.org/I138006243"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100736445","display_name":"Neha Singh","orcid":"https://orcid.org/0000-0001-9137-1103","observed_orcids":["https://orcid.org/0000-0001-9137-1103"]},"institutions":[{"id":"https://openalex.org/I138006243","display_name":"University of Arizona","ror":"https://ror.org/03m2x1q45","country_code":"US","type":"education","lineage":["https://openalex.org/I138006243"]},{"id":"https://openalex.org/I4390039223","display_name":"University of Arizona Cancer Center","ror":"https://ror.org/04tvx8690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039223"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neha Singh","raw_affiliation_strings":["2University of Arizona Cancer Center, University of Arizona, Tucson, Arizona"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2University of Arizona Cancer Center, University of Arizona, Tucson, Arizona","institution_ids":["https://openalex.org/I138006243","https://openalex.org/I4390039223"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013079586","display_name":"Libia A. Leuvano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I138006243","display_name":"University of Arizona","ror":"https://ror.org/03m2x1q45","country_code":"US","type":"education","lineage":["https://openalex.org/I138006243"]},{"id":"https://openalex.org/I4390039223","display_name":"University of Arizona Cancer Center","ror":"https://ror.org/04tvx8690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039223"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Libia A. Leuvano","raw_affiliation_strings":["2University of Arizona Cancer Center, University of Arizona, Tucson, Arizona"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2University of Arizona Cancer Center, University of Arizona, Tucson, Arizona","institution_ids":["https://openalex.org/I138006243","https://openalex.org/I4390039223"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006836320","display_name":"Valerie S. Calvert","orcid":"https://orcid.org/0000-0002-5075-7728","observed_orcids":["https://orcid.org/0000-0002-5075-7728"]},"institutions":[{"id":"https://openalex.org/I162714631","display_name":"George Mason University","ror":"https://ror.org/02jqj7156","country_code":"US","type":"education","lineage":["https://openalex.org/I162714631"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Valerie S. Calvert","raw_affiliation_strings":["3Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia","institution_ids":["https://openalex.org/I162714631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5115076571","display_name":"Emanuel F. Petricoin","orcid":"https://orcid.org/0000-0001-8787-5990","observed_orcids":["https://orcid.org/0000-0001-8787-5990"]},"institutions":[{"id":"https://openalex.org/I162714631","display_name":"George Mason University","ror":"https://ror.org/02jqj7156","country_code":"US","type":"education","lineage":["https://openalex.org/I162714631"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Emanuel F. Petricoin","raw_affiliation_strings":["3Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, Virginia","institution_ids":["https://openalex.org/I162714631"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028647628","display_name":"David T. Teachey","orcid":"https://orcid.org/0000-0001-7373-8987","observed_orcids":["https://orcid.org/0000-0001-7373-8987"]},"institutions":[{"id":"https://openalex.org/I1335321130","display_name":"Children's Hospital of Philadelphia","ror":"https://ror.org/01z7r7q48","country_code":"US","type":"funder","lineage":["https://openalex.org/I1335321130"]},{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David T. Teachey","raw_affiliation_strings":["4Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Division of Oncology, Department of Pediatrics, Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, Pennsylvania","institution_ids":["https://openalex.org/I1335321130","https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028049853","display_name":"Richard B. Lock","orcid":"https://orcid.org/0000-0002-3436-9071","observed_orcids":["https://orcid.org/0000-0002-3436-9071"]},"institutions":[{"id":"https://openalex.org/I31746571","display_name":"UNSW Sydney","ror":"https://ror.org/03r8z3t63","country_code":"AU","type":"education","lineage":["https://openalex.org/I31746571"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Richard B. Lock","raw_affiliation_strings":["5Children's Cancer Institute, School of Women's and Children's Health, UNSW Sydney, Sydney, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Children's Cancer Institute, School of Women's and Children's Health, UNSW Sydney, Sydney, Australia","institution_ids":["https://openalex.org/I31746571"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110947107","display_name":"Megha Padi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I138006243","display_name":"University of Arizona","ror":"https://ror.org/03m2x1q45","country_code":"US","type":"education","lineage":["https://openalex.org/I138006243"]},{"id":"https://openalex.org/I4390039223","display_name":"University of Arizona Cancer Center","ror":"https://ror.org/04tvx8690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039223"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Megha Padi","raw_affiliation_strings":["1Department of Molecular and Cellular Biology, University of Arizona, Tucson, Arizona","6Bioinformatics Shared Resource, University of Arizona Cancer Center, Tucson, Arizona"],"raw_orcid":"https://orcid.org/0000-0002-5526-4287","affiliations":[{"raw_affiliation_string":"1Department of Molecular and Cellular Biology, University of Arizona, Tucson, Arizona","institution_ids":["https://openalex.org/I138006243"]},{"raw_affiliation_string":"6Bioinformatics Shared Resource, University of Arizona Cancer Center, Tucson, Arizona","institution_ids":["https://openalex.org/I4390039223"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086393033","display_name":"Andrew S. Kraft","orcid":"https://orcid.org/0000-0003-3417-4845","observed_orcids":["https://orcid.org/0000-0003-3417-4845"]},"institutions":[{"id":"https://openalex.org/I138006243","display_name":"University of Arizona","ror":"https://ror.org/03m2x1q45","country_code":"US","type":"education","lineage":["https://openalex.org/I138006243"]},{"id":"https://openalex.org/I4390039223","display_name":"University of Arizona Cancer Center","ror":"https://ror.org/04tvx8690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039223"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Andrew S. Kraft","raw_affiliation_strings":["2University of Arizona Cancer Center, University of Arizona, Tucson, Arizona"],"raw_orcid":"https://orcid.org/0000-0003-3417-4845","affiliations":[{"raw_affiliation_string":"2University of Arizona Cancer Center, University of Arizona, Tucson, Arizona","institution_ids":["https://openalex.org/I138006243","https://openalex.org/I4390039223"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5009164151","display_name":"Sathish K.R. Padi","orcid":"https://orcid.org/0000-0002-5526-4287","observed_orcids":["https://orcid.org/0000-0002-5526-4287"]},"institutions":[{"id":"https://openalex.org/I138006243","display_name":"University of Arizona","ror":"https://ror.org/03m2x1q45","country_code":"US","type":"education","lineage":["https://openalex.org/I138006243"]},{"id":"https://openalex.org/I4390039223","display_name":"University of Arizona Cancer Center","ror":"https://ror.org/04tvx8690","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4390039223"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Sathish K.R. Padi","raw_affiliation_strings":["2University of Arizona Cancer Center, University of Arizona, Tucson, Arizona"],"raw_orcid":"https://orcid.org/0000-0002-5526-4287","affiliations":[{"raw_affiliation_string":"2University of Arizona Cancer Center, University of Arizona, Tucson, Arizona","institution_ids":["https://openalex.org/I138006243","https://openalex.org/I4390039223"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5009164151","https://openalex.org/A5086393033"],"corresponding_institution_ids":["https://openalex.org/I138006243","https://openalex.org/I4390039223"],"apc_list":null,"apc_paid":null,"fwci":1.1664,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":{"value":0.79235041,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"19","issue":"9","first_page":"1809","last_page":"1821"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pim-kinase-inhibitors","display_name":"PIM kinase inhibitors","score":0.8809999823570251},{"id":"https://openalex.org/keywords/t-cell-acute-lymphoblastic-leukemia","display_name":"T-cell acute lymphoblastic leukemia","score":0.9810000061988831},{"id":"https://openalex.org/keywords/early-t-cell-precursor-all","display_name":"early T-cell precursor ALL","score":0.902999997138977},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.8709999918937683},{"id":"https://openalex.org/keywords/nf-kappab-signaling","display_name":"NF-\u03baB signaling","score":0.828000009059906},{"id":"https://openalex.org/keywords/mtor-signaling","display_name":"mTOR signaling","score":0.7440000176429749},{"id":"https://openalex.org/keywords/pi3k-akt-signaling","display_name":"PI3K/Akt signaling","score":0.9810000061988831},{"id":"https://openalex.org/keywords/c-myc","display_name":"c-Myc","score":0.7950000166893005},{"id":"https://openalex.org/keywords/hoxa9","display_name":"HOXA9","score":0.9729999899864197},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.7770000100135803},{"id":"https://openalex.org/keywords/network-modeling","display_name":"network modeling","score":0.5630000233650208},{"id":"https://openalex.org/keywords/nf-kappab-p65-phosphorylation","display_name":"p65 phosphorylation","score":0.8240000009536743}],"concepts":[{"id":"https://openalex.org/C98175054","wikidata":"https://www.wikidata.org/wiki/Q18030550","display_name":"PIM1","level":4,"score":0.8542156219482422},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.7831904888153076},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.551436185836792},{"id":"https://openalex.org/C98490376","wikidata":"https://www.wikidata.org/wiki/Q14876060","display_name":"mTORC1","level":4,"score":0.5408419370651245},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.5385815501213074},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5172055959701538},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.5134409666061401},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.48137810826301575},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.47311827540397644},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.45939844846725464},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.429263710975647},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.35527297854423523},{"id":"https://openalex.org/C11960822","wikidata":"https://www.wikidata.org/wiki/Q242736","display_name":"Phosphorylation","level":2,"score":0.3215496838092804},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1779913306236267},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.1719176471233368},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.16554579138755798},{"id":"https://openalex.org/C2776414213","wikidata":"https://www.wikidata.org/wiki/Q183290","display_name":"Serine","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015398","descriptor_name":"Signal Transduction","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015854","descriptor_name":"Up-Regulation","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D015972","descriptor_name":"Gene Expression Regulation, Neoplastic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016271","descriptor_name":"Proto-Oncogene Proteins c-myc","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D016328","descriptor_name":"NF-kappa B","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D017423","descriptor_name":"Sequence Analysis, RNA","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018398","descriptor_name":"Homeodomain Proteins","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D020869","descriptor_name":"Gene Expression Profiling","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051573","descriptor_name":"Proto-Oncogene Proteins c-pim-1","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D051573","descriptor_name":"Proto-Oncogene Proteins c-pim-1","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D053263","descriptor_name":"Gene Regulatory Networks","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D054218","descriptor_name":"Precursor T-Cell Lymphoblastic Leukemia-Lymphoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D054218","descriptor_name":"Precursor T-Cell Lymphoblastic Leukemia-Lymphoma","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D058570","descriptor_name":"TOR Serine-Threonine Kinases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1158/1535-7163.mct-20-0160","doi":"https://doi.org/10.1158/1535-7163.mct-20-0160","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1535-7163.mct-20-0160","pdf_url":null,"source":{"id":"https://openalex.org/S48437117","display_name":"Molecular Cancer Therapeutics","issn_l":"1535-7163","issn":["1535-7163","1538-8514"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular Cancer Therapeutics","raw_type":"journal-article"},{"id":"pmid:32753387","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32753387","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular cancer therapeutics","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7484401","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7484401","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Mol Cancer Ther","raw_type":"Text"},{"id":"pmh:oai:unsworks.library.unsw.edu.au:1959.4/unsworks_71897","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/1959.4/unsworks_71897","pdf_url":null,"source":{"id":"https://openalex.org/S4306401737","display_name":"UNSWorks (University of New South Wales, Sydney, Australia)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I40053085","host_organization_name":"Australian Defence Force Academy","host_organization_lineage":["https://openalex.org/I40053085"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Molecular Cancer Therapeutics, 19, 9, 1809-1821","raw_type":"http://purl.org/coar/resource_type/c_6501"}],"best_oa_location":{"id":"pmh:oai:pubmedcentral.nih.gov:7484401","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7484401","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"Mol Cancer Ther","raw_type":"Text"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9789000153541565,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2739376974","display_name":"Targeting the Pim 1 Protein Kinase to Overcome Resistance to AKT Inhibitors","funder_award_id":"R01CA173200","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G6644976155","display_name":"OVERCOMING RESISTANCE TO INHIBITORS OF THE AKT PROTEIN KINASE BY MODULATION OF THE PIM KINASE PATHWAY","funder_award_id":"W81XWH1210560","funder_id":"https://openalex.org/F4320306078","funder_display_name":"U.S. Department of Defense"},{"id":"https://openalex.org/G9000909272","display_name":"University of Arizona Cancer Center - Cancer Center Support Grant","funder_award_id":"P30CA023074","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G903185969","display_name":null,"funder_award_id":"P30CA023074","funder_id":"https://openalex.org/F4320309707","funder_display_name":"University of Arizona Cancer Center"}],"funders":[{"id":"https://openalex.org/F4320306078","display_name":"U.S. Department of Defense","ror":"https://ror.org/0447fe631"},{"id":"https://openalex.org/F4320309707","display_name":"University of Arizona Cancer Center","ror":"https://ror.org/03m2x1q45"},{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":51,"referenced_works":["https://openalex.org/W1262816711","https://openalex.org/W1566535612","https://openalex.org/W1588676742","https://openalex.org/W1970701525","https://openalex.org/W1987835971","https://openalex.org/W1988356885","https://openalex.org/W1991221096","https://openalex.org/W1992841719","https://openalex.org/W1997238381","https://openalex.org/W2014313871","https://openalex.org/W2015493430","https://openalex.org/W2033341978","https://openalex.org/W2043634641","https://openalex.org/W2060605982","https://openalex.org/W2063462830","https://openalex.org/W2068605060","https://openalex.org/W2074464967","https://openalex.org/W2079410007","https://openalex.org/W2099297920","https://openalex.org/W2112811019","https://openalex.org/W2130410032","https://openalex.org/W2134118606","https://openalex.org/W2135817940","https://openalex.org/W2138218344","https://openalex.org/W2158987264","https://openalex.org/W2163964890","https://openalex.org/W2164691388","https://openalex.org/W2166306614","https://openalex.org/W2171218023","https://openalex.org/W2179997230","https://openalex.org/W2196407896","https://openalex.org/W2293361133","https://openalex.org/W2296706140","https://openalex.org/W2409557040","https://openalex.org/W2534173999","https://openalex.org/W2536094308","https://openalex.org/W2566426512","https://openalex.org/W2596205175","https://openalex.org/W2733265822","https://openalex.org/W2789376122","https://openalex.org/W2792984143","https://openalex.org/W2793421318","https://openalex.org/W2795073885","https://openalex.org/W2887273261","https://openalex.org/W2896283264","https://openalex.org/W2898600811","https://openalex.org/W2900569176","https://openalex.org/W2961239351","https://openalex.org/W4254538019","https://openalex.org/W4298419914","https://openalex.org/W6683297056"],"related_works":["https://openalex.org/W2980093462","https://openalex.org/W2741010848","https://openalex.org/W2596205175","https://openalex.org/W2009185488","https://openalex.org/W1997238381","https://openalex.org/W3020955619","https://openalex.org/W6991831607","https://openalex.org/W2305721882","https://openalex.org/W2951385566","https://openalex.org/W2570618841"],"abstract_inverted_index":{"Despite":[0],"significant":[1],"progress":[2],"in":[3,35,43,56,93,124,140,172,184,215],"understanding":[4],"the":[5,14,27,114,141,159,170,186],"genetic":[6],"landscape":[7],"of":[8,16,29,60,96,102,109,158,164,188],"T-cell":[9,37],"acute":[10],"lymphoblastic":[11],"leukemia":[12,54],"(T-ALL),":[13],"discovery":[15],"novel":[17],"therapeutic":[18],"targets":[19],"has":[20],"been":[21],"difficult.":[22],"Our":[23],"results":[24,192],"demonstrate":[25,193],"that":[26,73,113,177,196,210],"levels":[28],"PIM1":[30],"protein":[31,133],"kinase":[32],"is":[33],"elevated":[34],"early":[36],"precursor":[38],"ALL":[39],"(ETP-ALL)":[40],"but":[41],"not":[42,67],"mature":[44],"T-ALL":[45,88,222],"primary":[46],"samples.":[47],"Small-molecule":[48],"PIM":[49,129,218],"inhibitor":[50],"(PIMi)":[51],"treatment":[52,59],"decreases":[53],"burden":[55],"ETP-ALL.":[57],"However,":[58],"animals":[61],"carrying":[62],"ETP-ALL":[63],"with":[64,156,217],"PIMi":[65,79,206],"was":[66],"curative.":[68],"To":[69],"model":[70],"other":[71],"pathways":[72,121,195,209],"could":[74],"be":[75,212],"targeted":[76,214],"to":[77,205,220],"complement":[78],"activity,":[80],"HSB-2":[81,125,150,200],"cells,":[82],"previously":[83],"characterized":[84],"as":[85,147],"a":[86],"PIMi-sensitive":[87],"cell":[89,201],"line,":[90],"were":[91,122],"grown":[92],"increasing":[94],"doses":[95],"PIMi.":[97],"Gene":[98],"set":[99],"enrichment":[100,108],"analysis":[101],"RNA":[103],"sequencing":[104],"data":[105],"and":[106,119,144,166,207],"functional":[107],"network":[110],"modules":[111],"demonstrated":[112,138],"HOXA9,":[115],"mTOR,":[116,142],"MYC,":[117],"NF\u03baB,":[118],"PI3K-AKT":[120],"activated":[123,198],"cells":[126,151,175],"after":[127],"long-term":[128],"inhibition.":[130],"Reverse":[131],"phase":[132],"array-based":[134],"pathway":[135,179],"activation":[136,157],"mapping":[137],"alterations":[139],"PI3K-AKT,":[143],"NF\u03baB":[145,160,165],"pathways,":[146],"well.":[148],"PIMi-tolerant":[149],"contained":[152],"phosphorylated":[153],"RelA-S536":[154],"consistent":[155],"pathway.":[161],"The":[162],"combination":[163,216],"PIMis":[167],"markedly":[168],"reduced":[169],"proliferation":[171],"PIMi-resistant":[173],"leukemic":[174],"showing":[176],"this":[178],"plays":[180],"an":[181],"important":[182],"role":[183],"driving":[185],"growth":[187],"T-ALL.":[189],"Together":[190],"these":[191],"key":[194],"are":[197],"when":[199],"line":[202],"develop":[203],"resistance":[204],"suggest":[208],"can":[211],"rationally":[213],"kinases":[219],"inhibit":[221],"growth.":[223]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":5},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2020-08-10T00:00:00"}